Medical/Pharmaceuticals
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting
Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board BOSTON and ROLLE, Switzerland, June 10, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medic...
2026-06-10 20:00
3661
Alteogen Showcases ALT-B4's Potential to Transform ADC Development at World ADC Summit 2026
Preclinical data demonstrate enhanced systemic exposure and bioavailability, reduced dermal toxicity, and improved safety profile in ALT-B4-enabled ADC therapy Key Points * Superior PK: Subcutaneous administration of ADCs combined with ALT-B4 demonstrated rapid absorption, enhanced systemic e...
2026-06-10 17:00
4927
Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders
* Partnership will combine n-Lorem's cutting-edge antisense oligonucleotide (ASO) technology and Servier's R&D expertise with the aim of advancing ASO technology and delivering precision medicine approaches for patients across the world. * Servier strengthens its commitment to rare neurologic...
2026-06-10 16:00
4015
Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 10, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today an...
2026-06-10 12:06
5069
Carestream Launches NEW Lux HD 35 and Lux HD 43 Detectors for Medical Imaging
SHANGHAI, June 10, 2026 /PRNewswire/ -- Carestream announces the availability of its new generation of Cesium Iodide (CsI), glass-free X-ray Detector in markets all over the world, the Carestream Lux HD 35 and Lux HD 43 Detectors. Carestream NEW Lux HD 35 and Lux HD 43 Detectors The Lux HD 35 ...
2026-06-10 10:30
4277
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
BOSTON and SHENZHEN, China, June 10, 2026 /PRNewswire/ -- XtalPi (2228.HK), a leading platform in artificial intelligence (AI) and robotics-driven drug discovery, today announced a strategic partnership with a prominent international biopharmaceutical company. The collaboration focuses on develo...
2026-06-10 10:00
5331
Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China
SHANGHAI and HONG KONG, June 10, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune di...
2026-06-10 09:00
5379
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
HANGZHOU, China, SHANGHAI and BOSTON, June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseases, today announced a significant clinical milestone achieved by its globa...
2026-06-10 08:00
3585
PromptBio Launched All-New Agentic AI Platform For Life Sciences, Turning Scientific Intent Into Executable Experiments
The PromptBio Platform combines conversational AI with multi-agent orchestration to accelerate discovery from hypotheses to insights PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- PromptBio, a California-based leader in AI for life sciences, announced the launch of the All-New PromptBio Platfo...
2026-06-09 22:07
7132
First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
* COPD study initiation expands HBM9378/WIN378 (also known as SKB378) development into a second major respiratory disease * HBM9378/WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase 2 data expected in the second half of 2026 * HBM9378/WIN378 has th...
2026-06-09 20:23
5005
Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378
* COPD study initiation expands SKB378/WIN378 development into a second major respiratory disease * SKB378/WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase 2 data expected in the second half of 2026 * SKB378/WIN378 has the potential to be the firs...
2026-06-09 20:18
5764
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development
* SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention * SK bioscience is jointly investing with the RIGHT Foundation to drive process development that enhances both efficacy and productivity * "We are committed to improving public health through...
2026-06-09 20:00
3208
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis
* Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. * Unique whole-cell design eliminates cell teardown, reducing sample preparation time by >90%. * Industry-leading Coin Cell DSC temperature range from –80...
2026-06-09 20:00
3567
Renowned Urologist Dr. (Col) Rajeev Sood joins Manipal Hospital Gurugram to strengthen Comprehensive Urology and Kidney Transplant services
GURUGRAM, India, June 9, 2026 /PRNewswire/ -- Manipal Hospital Gurugram, one of India's leading multi-specialty healthcare institutions, has further strengthened its Department of Urology, Robotics & Renal Transplant with the onboarding ofDr. (Col) Rajeev Sood, Chairman – Urology, Robotics & Rena...
2026-06-09 14:41
3767
GEHPA-APAC Alliance Officially Launched to Advance Inclusive & Intelligent Education and Healthcare
SHENZHEN, China, June 9, 2026 /PRNewswire/ -- Under the theme "Together, Advancing Inclusive & Intelligent Education and Healthcare," Huawei successfully hosted theHuawei APAC Education & Healthcare Partners Summit 2026 on June 5 as part of the 2026 Global Education & Healthcare Partners China C...
2026-06-09 14:06
4456
Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel
SHANGHAI, June 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an exclusive ...
2026-06-09 08:21
5421
THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE
Backed by direct scientific research with elite collegiate and youth athletes, CryoTherm Palm's cooling technology made its debut with the England national team supporting training camps, pre-tournament friendlies, and sideline recovery protocols LOS ANGELES, June 8, 2026 /PRNewswire/ -- Therabo...
2026-06-08 20:05
5644
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
* Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks. * Delivers up to 2x increase in resolving power and sensitivity to identify and track low-level impurities for improved regulatory read...
2026-06-08 20:00
4347
Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey
HANGZHOU, China, June 8, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190; "Zylox-Tonbridge" or the "Company"), a Hong Kong-listed medical technology company focused on neurovascular and peripheral vascular interventional products and solutions, announced that it has ...
2026-06-08 18:19
4102
2026 ADA | Innovent Presents Multiple Clinical and Preclinical Results of Next-Generation Obesity & Metabolic Pipeline
SAN FRANCISCO and SUZHOU, China, June 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
2026-06-08 16:30
6691
Week's Top Stories
Most Reposted
Visa and Lianlian Advance Trusted B2B Agentic Commerce Through LoopXPay's First Live B2B Agentic Transaction
[Picked up by 322 media titles]
2026-07-24 12:00
A New Chapter Begins: Peach Blossoms Returns to Level 5 with the Debut of its Black Pearl One Diamond Tasting Journey
[Picked up by 300 media titles]
2026-07-23 16:00
Phuket Marriott Resort & Spa, Merlin Beach Elevates Guest Experience with New Dining and Family Facilities
[Picked up by 295 media titles]
2026-07-24 18:32
Courtyard by Marriott Phuket, Patong Beach Wins TripAdvisor Best of the Best Award
[Picked up by 290 media titles]
2026-07-24 16:25
MetaOptics to Deploy its Direct Laser Writer at the University of Arizona's Center of Semiconductor Manufacturing to Advance its U.S. Expansion
[Picked up by 289 media titles]
2026-07-22 07:30Most Read
A New Chapter Begins: Peach Blossoms Returns to Level 5 with the Debut of its Black Pearl One Diamond Tasting Journey
2026-07-23 16:00
11904
Visa and Lianlian Advance Trusted B2B Agentic Commerce Through LoopXPay's First Live B2B Agentic Transaction
2026-07-24 12:00
11433
Phuket Marriott Resort & Spa, Merlin Beach Elevates Guest Experience with New Dining and Family Facilities
2026-07-24 18:32
10611
Courtyard by Marriott Phuket, Patong Beach Wins TripAdvisor Best of the Best Award
2026-07-24 16:25
9448